Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatment

Jun Iwamoto, Azusa Seki, Yoshihiro Sato, Hideo Matsumoto, Tsuyoshi Tadeda, James K. Yeh

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The purpose of the present preclinical study was to determine whether vitamin K2 would promote bone healing in a rat femoral osteotomy model with or without glucocorticoid (GC) treatment. Thirty-eight 6 week-old female Sprague-Dawley rats underwent a unilateral osteotomy of the femoral diaphysis followed by intramedullary wire fixation and then were randomized into four groups that received the following treatment schedules: vehicle, vitamin K2, GC + vehicle, and GC + vitamin K2. GC (prednisolone, 2.5 mg/kg) was administered subcutaneously twice a week. Vitamin K2 (menatetrenone, 30 mg/ kg) was administered orally five times a week. After 8 weeks of treatment, the wires were removed and a bone histomorphometric analysis was performed on the bone tissue inside the callus. Vitamin K2 administration to GCuntreated rats decreased the osteoclast surface/bone surface (OcS/BS), osteoblast surface (ObS)/BS, eroded surface (ES)/BS, and bone formation rate (BFR)/BS and increased the lamellar area/bone area. Although GC treatment increased the ES/BS and decreased the ObS/BS, BFR/BS, and lamellar area/bone area, vitamin K2 administration to GC-treated rats decreased the OcS/BS and prevented an increase in the ES/BS and a decrease in the lamellar area/ bone area. These results suggested that vitamin K2 downregulated bone turnover and stimulated lamellar bone formation in GC-untreated rats and prevented an increase in bone resorption while maintaining bone formation and prevented a decrease in lamellar bone formation in GCtreated rats. Thus, vitamin K2 appears to be effective for promoting bone healing in a rat femoral osteotomy model with or without GC treatment.

Original languageEnglish
Pages (from-to)234-241
Number of pages8
JournalCalcified Tissue International
Volume86
Issue number3
DOIs
Publication statusPublished - 2010 Mar

Fingerprint

Vitamin K 2
Osteotomy
Thigh
Glucocorticoids
Bone and Bones
Osteogenesis
Therapeutics
Osteoclasts
Osteoblasts
Diaphyses
Bone Remodeling
Bony Callus
Bone Resorption
Prednisolone
Sprague Dawley Rats
Appointments and Schedules
Down-Regulation

Keywords

  • Bone healing
  • Callus
  • Glucocorticoid
  • Rat
  • Vitamin K

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatment. / Iwamoto, Jun; Seki, Azusa; Sato, Yoshihiro; Matsumoto, Hideo; Tadeda, Tsuyoshi; Yeh, James K.

In: Calcified Tissue International, Vol. 86, No. 3, 03.2010, p. 234-241.

Research output: Contribution to journalArticle

Iwamoto, Jun ; Seki, Azusa ; Sato, Yoshihiro ; Matsumoto, Hideo ; Tadeda, Tsuyoshi ; Yeh, James K. / Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatment. In: Calcified Tissue International. 2010 ; Vol. 86, No. 3. pp. 234-241.
@article{22348b4c48a94a3595dbb7731b2a659d,
title = "Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatment",
abstract = "The purpose of the present preclinical study was to determine whether vitamin K2 would promote bone healing in a rat femoral osteotomy model with or without glucocorticoid (GC) treatment. Thirty-eight 6 week-old female Sprague-Dawley rats underwent a unilateral osteotomy of the femoral diaphysis followed by intramedullary wire fixation and then were randomized into four groups that received the following treatment schedules: vehicle, vitamin K2, GC + vehicle, and GC + vitamin K2. GC (prednisolone, 2.5 mg/kg) was administered subcutaneously twice a week. Vitamin K2 (menatetrenone, 30 mg/ kg) was administered orally five times a week. After 8 weeks of treatment, the wires were removed and a bone histomorphometric analysis was performed on the bone tissue inside the callus. Vitamin K2 administration to GCuntreated rats decreased the osteoclast surface/bone surface (OcS/BS), osteoblast surface (ObS)/BS, eroded surface (ES)/BS, and bone formation rate (BFR)/BS and increased the lamellar area/bone area. Although GC treatment increased the ES/BS and decreased the ObS/BS, BFR/BS, and lamellar area/bone area, vitamin K2 administration to GC-treated rats decreased the OcS/BS and prevented an increase in the ES/BS and a decrease in the lamellar area/ bone area. These results suggested that vitamin K2 downregulated bone turnover and stimulated lamellar bone formation in GC-untreated rats and prevented an increase in bone resorption while maintaining bone formation and prevented a decrease in lamellar bone formation in GCtreated rats. Thus, vitamin K2 appears to be effective for promoting bone healing in a rat femoral osteotomy model with or without GC treatment.",
keywords = "Bone healing, Callus, Glucocorticoid, Rat, Vitamin K",
author = "Jun Iwamoto and Azusa Seki and Yoshihiro Sato and Hideo Matsumoto and Tsuyoshi Tadeda and Yeh, {James K.}",
year = "2010",
month = "3",
doi = "10.1007/s00223-010-9333-8",
language = "English",
volume = "86",
pages = "234--241",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatment

AU - Iwamoto, Jun

AU - Seki, Azusa

AU - Sato, Yoshihiro

AU - Matsumoto, Hideo

AU - Tadeda, Tsuyoshi

AU - Yeh, James K.

PY - 2010/3

Y1 - 2010/3

N2 - The purpose of the present preclinical study was to determine whether vitamin K2 would promote bone healing in a rat femoral osteotomy model with or without glucocorticoid (GC) treatment. Thirty-eight 6 week-old female Sprague-Dawley rats underwent a unilateral osteotomy of the femoral diaphysis followed by intramedullary wire fixation and then were randomized into four groups that received the following treatment schedules: vehicle, vitamin K2, GC + vehicle, and GC + vitamin K2. GC (prednisolone, 2.5 mg/kg) was administered subcutaneously twice a week. Vitamin K2 (menatetrenone, 30 mg/ kg) was administered orally five times a week. After 8 weeks of treatment, the wires were removed and a bone histomorphometric analysis was performed on the bone tissue inside the callus. Vitamin K2 administration to GCuntreated rats decreased the osteoclast surface/bone surface (OcS/BS), osteoblast surface (ObS)/BS, eroded surface (ES)/BS, and bone formation rate (BFR)/BS and increased the lamellar area/bone area. Although GC treatment increased the ES/BS and decreased the ObS/BS, BFR/BS, and lamellar area/bone area, vitamin K2 administration to GC-treated rats decreased the OcS/BS and prevented an increase in the ES/BS and a decrease in the lamellar area/ bone area. These results suggested that vitamin K2 downregulated bone turnover and stimulated lamellar bone formation in GC-untreated rats and prevented an increase in bone resorption while maintaining bone formation and prevented a decrease in lamellar bone formation in GCtreated rats. Thus, vitamin K2 appears to be effective for promoting bone healing in a rat femoral osteotomy model with or without GC treatment.

AB - The purpose of the present preclinical study was to determine whether vitamin K2 would promote bone healing in a rat femoral osteotomy model with or without glucocorticoid (GC) treatment. Thirty-eight 6 week-old female Sprague-Dawley rats underwent a unilateral osteotomy of the femoral diaphysis followed by intramedullary wire fixation and then were randomized into four groups that received the following treatment schedules: vehicle, vitamin K2, GC + vehicle, and GC + vitamin K2. GC (prednisolone, 2.5 mg/kg) was administered subcutaneously twice a week. Vitamin K2 (menatetrenone, 30 mg/ kg) was administered orally five times a week. After 8 weeks of treatment, the wires were removed and a bone histomorphometric analysis was performed on the bone tissue inside the callus. Vitamin K2 administration to GCuntreated rats decreased the osteoclast surface/bone surface (OcS/BS), osteoblast surface (ObS)/BS, eroded surface (ES)/BS, and bone formation rate (BFR)/BS and increased the lamellar area/bone area. Although GC treatment increased the ES/BS and decreased the ObS/BS, BFR/BS, and lamellar area/bone area, vitamin K2 administration to GC-treated rats decreased the OcS/BS and prevented an increase in the ES/BS and a decrease in the lamellar area/ bone area. These results suggested that vitamin K2 downregulated bone turnover and stimulated lamellar bone formation in GC-untreated rats and prevented an increase in bone resorption while maintaining bone formation and prevented a decrease in lamellar bone formation in GCtreated rats. Thus, vitamin K2 appears to be effective for promoting bone healing in a rat femoral osteotomy model with or without GC treatment.

KW - Bone healing

KW - Callus

KW - Glucocorticoid

KW - Rat

KW - Vitamin K

UR - http://www.scopus.com/inward/record.url?scp=77950866917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950866917&partnerID=8YFLogxK

U2 - 10.1007/s00223-010-9333-8

DO - 10.1007/s00223-010-9333-8

M3 - Article

VL - 86

SP - 234

EP - 241

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 3

ER -